§ 13F · FUND PROFILE
EcoR1 Capital, LLC.
AUM · $2.1B (13F)Positions · 33Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$156M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | ZYME | ZYMEWORKS INC | 22.97M | $600M | 29.2% | ±0% |
| 2 | ANAB | ANAPTYSBIO INC | 7.88M | $532M | 25.9% | ±0% |
| 3 | AKTS | AKTIS ONCOLOGY INC | 4.82M | $155M | 7.6% | ±0% |
| 4 | CGON | CG ONCOLOGY INC | 1.49M | $106M | 5.2% | +87% |
| 5 | ETON | ETON PHARMACEUTICALS INC | 2.17M | $79M | 3.8% | ±0% |
| 6 | CRSP | CRISPR THERAPEUTICS AG | 1.39M | $76M | 3.7% | ±0% |
| 7 | ORIC | ORIC PHARMACEUTICALS INC | 6.73M | $73M | 3.5% | ±0% |
| 8 | TRAX | FIRST TRACKS BIOTHERAPEUTICS | 3.17M | $64M | 3.1% | NEW |
| 9 | GLPG | LAKEFRONT BIOTHERAPEUTICS NV | 1.67M | $50M | 2.4% | ±0% |
| 10 | NGNE | NEUROGENE INC | 1.27M | $40M | 1.9% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE ECOR1 SIGNAL
AC read
EcoR1 Capital, LLC is a Other fund managing $2.1 billion in assets. The fund runs a portfolio of 33 positions.
Read the full dossier →